Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
137 studies found for:    vulvar cancer
Show Display Options
Rank Status Study
21 Active, not recruiting Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva
Condition: Vulvar Cancer
Interventions: Drug: imiquimod;   Procedure: biopsy;   Procedure: therapeutic conventional surgery
22 Recruiting Interest of the Confocal Microscope in the Diagnosis of Epidermoid Carcinoma of the Vulva and Their Precursors
Conditions: Vulvar Mucosa Lesions;   Vulvar Intraepithelial Neoplasia
Interventions: Other: photographies;   Procedure: biopsy normal area
23 Withdrawn Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox.
Condition: Vulvar Cancer
Intervention: Drug: Ciclopirox
24 Unknown  Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva
Conditions: Cervical Cancer;   Vulvar Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
25 Completed Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes Curage
Conditions: Vulvar Neoplasms;   Skin Neoplasms
Interventions: Device: ultracision;   Device: classical lymphadenectomy
26 Completed The Impact of the "WOMAN-PRO II Program" on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom Prevalence
Conditions: Vulvar Cancer;   Vulvar Intraepithelial Neoplasia
Interventions: Behavioral: standardized care (Intervention I);   Behavioral: Standardized care + WOMAN-PRO II program (Intervention II)
27 Not yet recruiting Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas
Conditions: Cervical Cancer;   Vulvar Cancer;   Anal Cancer;   Oropharynx Cancer
Intervention: Other: CaptHPV method
28 Completed
Has Results
A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501) in Women (V501-019)
Conditions: Healthy;   Papillomavirus Infection
Interventions: Biological: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine;   Biological: Comparator: Placebo
29 Completed
Has Results
Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)
Conditions: Cervical Cancer;   Genital Warts
Interventions: Biological: V501;   Biological: Comparator: Placebo;   Biological: Human Papillomavirus (HPV) 16 Monovalent
30 Completed Tension-free Vaginal Tape (TVT) Versus Bulking Agent for the Treatment of Post Vulvectomy Urinary Incontinence
Condition: Urinary Incontinence, Stress
Interventions: Procedure: Tension free vaginal tape;   Procedure: Bulking agent injection
31 Completed
Has Results
Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar
Condition: Squamous Cell Carcinoma
Intervention: Drug: Erlotinib
32 Terminated Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer
Condition: Cervical Cancer
Interventions: Drug: Velcade (bortezomib);   Drug: Irinotecan
33 Completed Sentinel Node and Endometrial Cancer
Condition: Endometrial Neoplasms
Intervention: Procedure: Detection of sentinel node
34 Completed Effectiveness of an Individualized Symptom Education Program (ISEP)
Conditions: Uterine Cancer;   Cervical Cancer;   Vaginal Cancer;   Vulvar Cancer
Intervention: Behavioral: Individualized Symptom Education
35 Completed
Has Results
A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)
Conditions: Cervical Cancers;   Vulvar Cancers;   Vaginal Cancers;   Genital Warts
Interventions: Biological: V503;   Biological: Placebo to V503
36 Recruiting A Study to Investigate the Safety and Efficacy of Nivolumab and Nivolumab Plus Ipilimumab in Virus-associated Tumors
Condition: Various Advanced Cancer
Interventions: Drug: Nivolumab;   Drug: Ipilimumab
37 Unknown  Sentinel Node in Ovarian Cancer
Conditions: Ovarian Cancer;   Sentinel Node
Intervention: Procedure: blue dye and radioactive tracer
38 Completed Clobetasol Versus Pimecrolimus for Vulvar Lichen Sclerosus
Condition: Lichen Sclerosus
Interventions: Drug: pimecrolimus and clobetasol;   Drug: clobetasol 0.05% cream
39 Completed Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
Conditions: Human Papillomavirus;   Infection
Intervention:
40 Completed Magnetic Resonance Imaging Guided Gynecologic Brachytherapy
Conditions: Cervix Neoplasms;   Uterine Neoplasms;   Vaginal Neoplasms;   Vulvar Neoplasms
Intervention: Procedure: Brachytherapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.